Pediatric Cancers

• Beste egile batzuk: Agarwal, Saurabh (Argitaratzailea), Yang, Jianhua (Argitaratzailea)
• Formatua: Baliabide elektronikoa Liburu kapitulua
• Hizkuntza: ingelesa
• Argitaratua: Basel MDPI - Multidisciplinary Digital Publishing Institute 2023
• Gaiak: Medicine; Oncology; infections; cancer; children; bacteremia; pneumonia; sarcoma; solid tumor; outcome; KI67; EZRIN; 18F-FDG PET/CT; random forest; radiogenomics; chemotherapy response; metastasis; serine-threonine kinase receptor-associated protein; neuroblastoma; CRISPR-Cas9; metronomic chemotherapy; maintenance therapy; high-risk; Ewing sarcoma; RNA-binding proteins; regulation network; prognosis prediction; risk model; melanotic neuroectodermal tumor of infancy; inoperable; metastatic; recurrent; chemotherapy; adjuvant; neoadjuvant; systemic treatment; childhood malignant bone tumors; survivorship; late effects; somatic disease; cohort study; rhabdomyosarcoma; targeted therapies; cell surface proteomics; B7-H3; stress; allostasis; stress regulatory pathways; stress dysregulation; stress reactivity; early life stress; childhood cancer; cytotoxic cancer treatment; interventions; ependymoma; risk stratification; molecular group; prognosis; nephroblastoma; clinical malformations; cancer predisposition syndromes; tumor surveillance; n/a; DSRCT; EWSR1-WT1; preclinical model; in vitro model; pediatric cancer; pediatric; brain; tumor; medulloblastoma; glioma; natural products; drug discovery; fungal secondary metabolites; soil microbes; RH30; RD; EZH2; epigenetic; EPZ005687; DZNep; AdOx; malignant rhabdoid tumor; hepatoblastoma; small cell undifferentiated (SCUD) hepatoblastoma; SMARCB1; INI1; pediatric liver tumors; drug repurposing; PI3K pathway; epigenetics; Fimepinostat; LPAR1; LPA; tumor metastasis; bioinformatics analysis; ulixertinib; ERK inhibition; combination therapy; c-Myc/N-Myc; cell differentiation; ATRA; SOX4; diffuse intrinsic pontine glioma; immunotherapy; immune microenvironment; immune checkpoint inhibitor; vaccine; oncolytic virus; myeloid sarcoma; chloroma; acute myeloid leukemia; pediatric cancers; VIPN; DIC; MDR; drug transporters; childhood acute leukemia; early complication; hyperleukocytosis; risk factor; survival outcome
• Sarrera elektronikoa: DOAB: download the publication; DOAB: description of the publication

Childhood cancer or pediatric cancer is one of the leading causes of death among children. Treatment strategies for pediatric cancers include chemotherapy, surgery, radiation, and stem cell transplantation. These therapeutic regimens are well known to develop highly toxic and long-lasting side-effec...